NM_016204.4:c.88C>T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 6P and 4B. PVS1_StrongPP5_ModerateBS2
The NM_016204.4(GDF2):c.88C>T(p.Arg30*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000548 in 1,459,512 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_016204.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248924Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134990
GnomAD4 exome AF: 0.00000548 AC: 8AN: 1459512Hom.: 0 Cov.: 31 AF XY: 0.00000689 AC XY: 5AN XY: 725698
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Telangiectasia, hereditary hemorrhagic, type 5 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg30*) in the GDF2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GDF2 are known to be pathogenic (PMID: 26801773, 31661308, 31727138). This variant is present in population databases (rs782274691, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with GDF2-related conditions. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at